heparin remains the most common anticoagulant in use and one of the most commonly prescribed drugs to hospitalized patients. However, the biologic variability and immunogenicity limit its utility.

Atrial fibrillation (AF) is a common heart condition that affects about one in three people at some point in their lives. It ...

Nutritious foods aren’t always harmless. Grapefruit juice, greens, and other staples can disrupt medications. Discover five ...

Patients with atrial fibrillation are typically prescribed an anticoagulant, or blood thinner, to reduce the risk of stroke, ...

Researchers evaluated a drug that represents a new class of anticoagulants known as Factor XI inhibitors for treating patients with atrial fibrillation as part of the AZALEA-TIMI 71 Study. The trial ...

Use of Anticoagulant Drug After Aortic Valve Replacement Lowers ... combination of a particular gene mutation, estrogen use, or common medical conditions -- specifically: obesity, high blood ...

The cutoff values for each continuous variable are presented in Table 2. Table 3. Risk scoring scale for anticoagulant drugs-related ICH. The Nomogram (Figure 2) was also constructed based on the beta ...

The continued quest for an 'ideal anticoagulant' led to the US FDA's recent approval of dabigatran etexilate, a prodrug for dabigatran (Pradaxa®, Boehringer Ingelheim), rivaroxaban, a Factor Xa ...

The ageing population and the increasing prevalence of conditions like atrial fibrillation are driving significant growth in the anticoagulant reversal drugs market in the Asia Pacific ...

Clinically significant reductions in bleeding underscore abelacimab’s strong potential to address an unmet need for patients ...